B-Cell Activating Factor, antagonists & inhibitors
- Name
- B-Cell Activating Factor, antagonists & inhibitors
- Accession Number
- DBCAT002776
- Description
Not Available
- Drugs
Drug Drug Description Tabalumab Tabalumab has been used in trials studying the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus, among others. - Drugs & Drug Targets
Drug Target Type